HYLAFEM BORICUM ACIDUM 3X

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
HYLAFEM BORICUM ACIDUM 3X
Generic name
BORICUM ACIDUM
Manufacturer
U.S. PHARMACEUTICAL CORPORATION
Product type
HUMAN OTC DRUG
SPL set ID
fcd50c95-2522-418f-a2f3-de7e22622363
SPL ID
108fa2fe-f7a1-4c68-927e-70ef523e81d0
Version
5
Effective date
2022-11-17
Source export date
2026-10-12
Source partition
1
Source file
https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/7928c8e8c6256620071a8b7e5b93eb8dfa543649c08d17a01ea02251012ba58c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:26:33
Harmonized routes table
Harmonized routes
VAGINAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For vaginal use only Do not use if you have never had a vaginal yeast infection diagnosed by a doctor.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

Adverse reactions and side effects The adverse effects are considered mild and may include watery discharge, erythema, or slight burning sensation. You should contact your healthcare provider for medical advice about adverse events or report a serious adverse event, by contacting US Pharmaceutical Corporation at the address listed below. Distributed by: US Pharmaceutical Corporation 2443 Park Central Blvd Decatur, GA 30035, USA

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.